Coefficient Capital
VC Fund
New York, United States
Coefficient Capital is a VC fund in New York focused on Food and Beverage and Health Care. Coefficient Capital leads investments in high-growth consumer brands that align the physical world with the digital universe. It partners with entrepreneurs to build brands, tell stories and engage consumers across the digital and physical worlds. It offers capital, expertise, connections, and its own brand tool kit to help businesses grow.
- Total investments:
- 23
- Last investment:
- Lead investor:
- 52%
- Fund size:
- $286M
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Coefficient Capital invests in
Stages Coefficient Capital invests in
Countries Coefficient Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Series A
- $5.7M–$25M
- Series B
- $12M–$106M
- Venture - Series Unknown
- $3M–$24M
Investment Focus
Industry
- Food and Beverage 11 (48%)
- Health Care 5 (22%)
- Food Processing 4 (17%)
- Wellness 3 (13%)
- Nutrition 3 (13%)
Stage
- Series B 8 (35%)
- Venture - Series Unknown 5 (22%)
- Series A 4 (17%)
- Series C 3 (13%)
- Seed 1 (4%)
Country
- United States 12 (52%)
- Germany 3 (13%)
- United Kingdom 2 (9%)
- Sweden 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Andrew Goletka
Managing Partner&Founding Partner
|
Managing Partner&Founding Partner | Total investments: 7 | Find email | |
Arpon Ray
Senior Principal & COO
|
Senior Principal & COO | Total investments: 2 | Find email | |
Franklin Isacson
Managing Partner&Founding Partner
|
Managing Partner&Founding Partner | Total investments: 2 | Find email | |
Anna Whiteman
Principal
|
Principal | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Starship Technologies is a robotics company building fleets of self-driving delivery robots designed to deliver goods locally within 30 minutes. The robots drive autonomously 99% of the time to make safe and environmentally friendly curb-side deliveries from a local hub. They also offering people convenient new services that improve everyday life.Starships Technologies robots are equipped with a sensor suite that includes cameras, GPS, and inertial measurement units. The company's aim is to fundamentally reshape how goods are shipped and delivered, and make local delivery, ultimately, free. It also enables a new era of instant delivery that works around your schedule at much lower costs.Starships Technologies was founded in 2014 and is headquartered in San Francisco, California. | $50M / Series C / Oct 15, 2025 | ||
| Sauz is a food and beverages company that offers a variety of pasta sauce. | $12M / Venture - Series Unknown / Jun 11, 2025 | ||
| Gorgie operates as an energy-drink startup. | $24.5M / Series A / Apr 29, 2025 | ||
| Untamed uses fresh, human-grade ingredients to help cats enjoy happier, healthier lives. Chicken breast and liver, tuna steak, salmon fillet, duck breast, shrimp, sardine, and mackerel fillets are offered. | $12.8M / Series B / Apr 08, 2025 | ||
| Milano Vice is building a new virtual food brand by working with professional kitchens to prepare and deliver delicious pizzas to home. | Venture - Series Unknown / Mar 01, 2025 | ||
| KoRo is a snacking brand that offers a range of products from natural foods to clean-label snacks and functional foods. It specializes in superfoods, dried fruits, nuts, seeds, cereals, various butter variety, supplements, organic drinks, juices, and protein bars. | $36.9M / Series C / Nov 20, 2024 | ||
| ZOE is a personalized nutrition company that operates the world's largest nutrition-science study, as well as the ZOE Health Study (formerly ZOE COVID Study). It improves the health of millions by utilizing data on a previously unimagined scale and unraveling the complex relationship between food, lifestyle, and health. The ZOE program beginswith an at-home test and provides members with personalized advice on how to eat for their bodies and long-term health.Its science is based on the realization that everyone reacts differently to food and that gut bacteria play an important role in health. ZOE research has been published in peer-reviewed journals such as Nature Medicine, Nature Metabolism, The Lancet, Gut, and others. | $15M / Series B / Jul 29, 2024 | ||
| Milano Vice is building a new virtual food brand by working with professional kitchens to prepare and deliver delicious pizzas to home. | $8.9M / Series A / Dec 06, 2023 | ||
| Kate Farms offers nutritionally advanced, plant-based tube feeding, and enteral formulas that are well-tolerated by patients. Free of common allergens, including soy, dairy, and corn, clinicians report patients have experienced decreased symptoms of GI intolerance, improved weight or linear growth, and overall improved nutritional status. KateFarms is now the #1 plant-based enteral formula on the market. They’re gaining a better understanding of the role nutrition has on health, both in the management of care and direct therapeutic impact. Ingredients matter and our formulas are designed to deliver outcomes that matter. They pair leading-edge science and technologies with ingredients from nature in unique formulations that work with the bodies. This combination offers the potential for significant improvements to health and to the practice of healthcare. Today doctors, dietitians, parents, caregivers, and those with medical and dietary needs are empowered with the choice of a new formula. It’s the nourishment that makes them feel good because everyone deserves nothing less. | $75M / Series C / Sep 19, 2022 | ||
| Milano Vice is building a new virtual food brand by working with professional kitchens to prepare and deliver delicious pizzas to home. | $5.9M / Seed / Jul 12, 2022 | ||
| See all 23 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does Coefficient Capital invest in?
Coefficient Capital invests primarily in Food and Beverage, Health Care and Food Processing startups, most often at Series B and Venture - Series Unknown stage. Most of the 23 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does Coefficient Capital invest in?
Coefficient Capital typically joins rounds of $5.7M–$25M at Series A, $12M–$106M at Series B and $3M–$24M at Venture - Series Unknown. These are whole funding-round sizes, not Coefficient Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds Coefficient Capital took part in.
How do I contact Coefficient Capital?
Public channels for Coefficient Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Coefficient Capital?
The team at Coefficient Capital includes Andrew Goletka (Managing Partner&Founding Partner), Arpon Ray (Senior Principal & COO) and Franklin Isacson (Managing Partner&Founding Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
